Cash Flow - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -93.09 | -81.23 | -73.02 | -88.39 | -117.04 | -30.73 | 0.14 |
| Cash flow from investing | -0.60 | -0.36 | -7.35 | -24.93 | -21.55 | -9.08 | -9.08 |
| Cash flow from financing | 274.59 | 76.68 | 136.39 | 52.10 | 39.08 | 291.06 | 291.06 |
| Change in cash | 180.90 | -4.90 | 56.02 | -61.22 | -99.51 | 251.25 | 282.12 |
Show Quarterly Cash Flow
Cash Flow - Taysha Gene Therapies, Inc. (TSHA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -40.88 | -26.72 | -24.17 | -20.18 | -22.02 | -18.31 | -21.62 | -21.50 | -19.80 | -16.12 | -17.95 | -18.77 | -20.19 | 14.28 | -28.81 | -33.35 | -40.94 | -40.26 | -31.93 | -22.82 | -22.04 | -19.85 | -6.72 | -2.47 | -1.70 | 0.00 |
| Cash flow from investing | -3.02 | -0.25 | -0.05 | 0.06 | -0.37 | 0.01 | -0.04 | -0.20 | -0.14 | -0.01 | -3.49 | 0.05 | -3.90 | 0.05 | -3.02 | -8.11 | -11.43 | -8.52 | -4.00 | -8.50 | -0.53 | -6.05 | -0.03 | -3.00 | -1.50 | |
| Cash flow from financing | 0.71 | 49.56 | 8.80 | 216.29 | -0.05 | -0.36 | 6.60 | 70.47 | -0.02 | -4.25 | 140.63 | 0.38 | -0.37 | 41.67 | -0.10 | 11.08 | -0.11 | 9.11 | 29.98 | 26.25 | -1.48 | -1.48 | 274.18 | 0.34 | 18.03 | |
| Change in cash | -43.19 | 22.59 | -15.42 | 196.17 | -22.44 | -18.65 | -15.06 | 48.76 | -19.96 | -20.38 | 119.20 | -18.34 | -24.46 | 55.99 | -31.93 | -30.39 | -52.47 | -39.67 | -5.96 | -5.06 | -24.05 | -27.38 | 267.43 | -5.13 | 14.83 | 0.00 |